In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study
- Authors
- Gadhe, Changdev G.; Balupuri, Anand; Cho, Seung Joo
- Issue Date
- 2-Nov-2015
- Publisher
- TAYLOR & FRANCIS INC
- Keywords
- CCR8; membrane protein; homology modeling; docking; MD simulation
- Citation
- JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, v.33, no.11, pp.2491 - 2510
- Journal Title
- JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Volume
- 33
- Number
- 11
- Start Page
- 2491
- End Page
- 2510
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/9928
- DOI
- 10.1080/07391102.2014.1002006
- ISSN
- 0739-1102
- Abstract
- Human CC-chemokine receptor 8 (CCR8) is a crucial drug target in asthma that belongs to G-protein-coupled receptor superfamily, which is characterized by seven transmembrane helices. To date, there is no X-ray crystal structure available for CCR8; this hampers active research on the target. Molecular basis of interaction mechanism of antagonist with CCR8 remains unclear. In order to provide binding site information and stable binding mode, we performed modeling, docking and molecular dynamics (MD) simulation of CCR8. Docking study of biaryl-ether-piperidine derivative (13C) was performed inside predefined CCR8 binding site to get the representative conformation of 13C. Further, MD simulations of receptor and complex (13C-CCR8) inside dipalmitoylphosphatidylcholine lipid bilayers were performed to explore the effect of lipids. Results analyses showed that the Gln91, Tyr94, Cys106, Val109, Tyr113, Cys183, Tyr184, Ser185, Lys195, Thr198, Asn199, Met202, Phe254, and Glu286 were conserved in both docking and MD simulations. This indicated possible role of these residues in CCR8 antagonism. However, experimental mutational studies on these identified residues could be effective to confirm their importance in CCR8 antagonism. Furthermore, calculated Coulombic interactions represented the crucial roles of Glu286, Lys195, and Tyr113 in CCR8 antagonism. Important residues identified in this study overlap with the previous non-peptide agonist (LMD-009) binding site. Though, the non-peptide agonist and currently studied inhibitor (13C) share common substructure, but they differ in their effects on CCR8. So, to get more insight into their agonist and antagonist effects, further side-by-side experimental studies on both agonist (LMD-009) and antagonist (13C) are suggested.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/9928)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.